The level of miR-217 expression was dramatically decreased in NSCLC tissues and cells, and it was discovered that upregulation of miR-217 may prevent NSCLC growth and progression by limiting the production of proteins involved in the PI3K pathway (56). This evidence concerns the gene PIK3CG and non-small cell lung carcinoma.